Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Medicine, Oncology, Hazard ratio, Lenvatinib, Internal medicine, and Pembrolizumab.
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
Current advances and future directions in combined hepatocellular and cholangiocarcinoma
Surgical quality determines the long-term survival superiority of right over left thoracic esophagectomy for localized esophageal squamous cell carcinoma patients: a real-world multicenter study
Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy